Maynard Um
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) PT Lowered to $37 at Guggenheim
-
-
-
-
-
-
-
Important Notice to Long-Term Shareholders of Unicycive Therapeutics, Inc. (UNCY): Grabar Law Office Is Investigating Claims on Your Behalf
-
-
-
-
-
-
-
Unicycive Therapeutics, Inc (UNCY) Misses Q3 EPS by 46c
-
-
-
-
-
-
-
Unicycive Therapeutics, Inc. (UNCY) Misses Q2 EPS by 143c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Unicycive Therapeutics (UNCY)
-
-
-
-
-
-
-
Unicycive Therapeutics (UNCY) PT Raised to $7.50 at H.C. Wainwright
-
-
-
-
-
-
-
Unicycive Therapeutics, Inc (UNCY) Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology
-
410,915 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

